You are here: Home » Companies ยป Results
High taxation limits growth of India's super luxury car market: Lamborghini
icon-arrow-left
L&T Realty, CapitaLand tie up to develop 6 mn sq ft of prime office space
Business Standard

Divi's Lab Q2 net profit dips 18% to Rs 494 cr, revenue down to Rs 1,854 cr

The drug firm had reported a net profit of Rs 606 crore in the July-September period of last fiscal

Topics
Divi's Laboratories | Divis Laboratories | Q2 results

Press Trust of India  |  New Delhi 



Divi's Laboratories
Shares of the company on Monday ended 8.63 per cent at Rs 3,422 apiece on the BSE

Divi's Laboratories on Monday said its consolidated net profit declined by 18 per cent to Rs 494 crore in the second quarter of the current financial year.

The drug firm had reported a net profit of Rs 606 crore in the July-September period of last fiscal.

Revenue from operations declined to Rs 1,854 crore in the September quarter as against Rs 1,987 crore in the year-ago period.

Shares of the company on Monday ended 8.63 per cent at Rs 3,422 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Mon, November 07 2022. 16:34 IST

RECOMMENDED FOR YOU

.